Crystal structure of a zinc-activated variant of human carbonic anhydrase I, CA I Michigan 1: Evidence for a second zinc binding site involving arginine coordination

被引:45
作者
Ferraroni, M
Tilli, S
Briganti, F
Chegwidden, WR
Supuran, CT
Wiebauer, KE
Tashian, RE
Scozzafava, A
机构
[1] Lake Erie Coll Osteopath Med, Erie, PA 16509 USA
[2] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA
[3] Univ Florence, Dipartimento Chim, Chim Bioorgan Lab, I-50019 Sesto Fiorentino, Italy
关键词
D O I
10.1021/bi0120446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human genetic variant carbonic anhydrase I (CA I) Michigan 1 results from a single point mutation that changes His 67 to Arg in a critical region of the active site. This variant of the zinc metalloenzyme appears to be unique in that it possesses an esterase activity that is specifically enhanced by added free zinc ions. We have determined the three-dimensional structure of human CA I Michigan 1 by X-ray crystallography to a resolution of 2.6 Angstrom. In the absence of added zinc ions, the mutated residue, Arg 67, points out of the active site, hydrogen bonding with the carboxylate of Asn 69. This contrasts with the orientation of His 67, in the native isozyme, which points into the active site. The orientations of His 94, His 96, and His 119, that coordinate the catalytic zinc ion, and of the catalytically critical Thr 199-Glu 106 hydrogen bonding system, are largely unchanged in the mutant. The structure of an enzyme adduct with a second zinc bound was determined to a resolution of 2.0 Angstrom. The second zinc ion is coordinated to His 64, His 200, and Arg 67. This arginine residue reverses its orientation on zinc binding and turns into the active site. The residues at these three positions have been implicated in determining the specific kinetic properties of native CA I. This is, to our knowledge, the first example of a zinc ion coordinating with an arginine residue in a Zn(II) enzyme.
引用
收藏
页码:6237 / 6244
页数:8
相关论文
共 45 条
  • [1] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [2] FINE TUNING OF THE CATALYTIC PROPERTIES OF CARBONIC-ANHYDRASE - STUDIES OF A THR200-] HIS VARIANT OF HUMAN ISOENZYME-II
    BEHRAVAN, G
    JONSSON, BH
    LINDSKOG, S
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 190 (02): : 351 - 357
  • [3] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [4] STRUCTURE DETERMINATION OF MURINE MITOCHONDRIAL CARBONIC-ANHYDRASE-V AT 2.45-ANGSTROM RESOLUTION - IMPLICATIONS FOR CATALYTIC PROTON-TRANSFER AND INHIBITOR DESIGN
    BORIACKSJODIN, PA
    HECK, RW
    LAIPIS, PJ
    SILVERMAN, DN
    CHRISTIANSON, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) : 10949 - 10953
  • [5] Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine
    Briganti, F
    Mangani, S
    Orioli, P
    Scozzafava, A
    Vernaglione, G
    Supuran, CT
    [J]. BIOCHEMISTRY, 1997, 36 (34) : 10384 - 10392
  • [6] BRIGANTI F, 1998, GENE FAM ISOZYME B, V31, P43
  • [7] STUDY OF HISTIDINE RESIDUES OF HUMAN CARBONIC ANHYDRASE-B USING 270 MHZ PROTON MAGNETIC-RESONANCE
    CAMPBELL, ID
    LINDSKOG, S
    WHITE, AI
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1974, 90 (03) : 469 - 489
  • [8] CANTOR CR, 1980, BIOPHYSICAL CHEM, P42
  • [9] DRUG-PROTEIN INTERACTIONS - REFINED STRUCTURES OF 3 SULFONAMIDE DRUG COMPLEXES OF HUMAN CARBONIC-ANHYDRASE-I ENZYME
    CHAKRAVARTY, S
    KANNAN, KK
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (02) : 298 - 309
  • [10] Chegwidden WR, 2000, EXS, V90, P13